Navigation Links
Biomarker May Signal HIV Progression
Date:3/28/2008

Increase in specific white blood cells could warn doctors early to change treatments

FRIDAY, March 28 (HealthDay News) -- Researchers at Temple University think they may have found a blood marker that denotes the progression of the virus that causes AIDS.

The researchers found an increase in the CD163+/CD16+ monocyte subset may coincide with the advancement of human immunodeficiency virus (HIV), according to a study published in the March issue of AIDS Research and Human Retroviruses.

"It looks like, based on these correlations, that this particular cell type may be involved in immune impairment and the progression of HIV," Jay Rappaport, a professor of neuroscience and neurovirology who oversaw the study, said in a prepared statement. "Is it a good prognostic indicator? If you have a lot of these monocytes, does it mean you are going to progress into AIDS faster? Right now, all we know is what the correlations are."

A monocyte is a specific white blood cell, a part of the human body's immune system that protects against blood-borne pathogens and moves quickly to sites of infection within the body's tissues. As monocytes enter tissue, they undergo a series of changes.

The researchers investigated these alterations by examining 18 patients with HIV and seven individuals without HIV.

"We did, indeed, find that patients with detectable virus had an increase of this monocyte subset that correlated with the amount of virus they had in their blood," study author Tracy Fischer-Smith, an associate scientist in Temple's Neuroscience Department, said in a prepared statement. "We were surprised to find that in patients with CD4+ T-cell counts of less than 450 cells per microliter [200 or less per microliter is defined as AIDS], the increase of this monocyte subset correlates inversely with the number of T-cells."

Fischer-Smith said this finding suggests that as the monocyte cells are increasing, these patients are losing CD4+ T-cells, which are critical for maintaining one's immune system.

"This may actually provide an earlier window into what is happening with HIV-infected patients where we might be able to see that immune impairment is taking place before we see a dramatic loss of CD4+ T-cells," she said.

The researchers plan to expand this study by following a cohort of patients over time to see if their findings can provide doctors with an early warning system and help them design better therapeutic strategies, Fischer-Smith said.

More information

The U.S. Department of Health and Human Services has more about HIV and AIDS.



-- Kevin McKeever



SOURCE: Temple University, news release, March 28, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Expansion of monocyte subset could serve as a biomarker for HIV progressions
2. Biomarkers and Innovation Push Global Cancer Diagnostics Market Toward $8 Billion
3. Biomarkers for Mood May Alter Psychiatric Treatments
4. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
5. Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer
6. New developments in biomarkers for epithelial ovarian cancer
7. Biomarkers for Alzheimers disease can be trusted in clinical trials
8. JDRF and Lilly partner to fund research to identify beta cell biomarkers
9. Biomarkers predict risk for invasive breast cancer years before the tumor develops
10. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
11. Biomarker may be an early predictor of advanced breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... At Hallmark Nameplate, their commitment ... they have achieved certification to ISO 13485. This certification is another way they are ... date products and services that they need. , The ISO 13485 Certification is a ...
(Date:1/18/2017)... ... 2017 , ... The Hear the World Foundation, a Sonova ... of cochlear implants. In February 2017, the first three children with profound hearing ... leading an independent life. This engagement builds on the support the Hear the ...
(Date:1/17/2017)... ... January 17, 2017 , ... January is National Stalking Awareness Month (NSAM), now ... in the corners and commit the crime of stalking, a very real danger to many ... often overlooked factor in stalking and other crimes. , “Stalking: know it. Name it. Stop ...
(Date:1/17/2017)... ... January 17, 2017 , ... For breast cancer clinicians and ... or those who desire a more intimate review and analysis of its highlights, a ... to Bedside—is being offered by Imedex on February 4, 2017 in Chicago. Chaired by ...
(Date:1/17/2017)... ... January 17, 2017 , ... Kevin Harrington (one of the original Sharks from ... campaigns regarding the topic of Beauty and Personal Care. , Everyone ... better way to commit to these changes than beginning with personal care and beauty ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017  Tarix Orphan LLC ... has granted a Rare Pediatric Disease (RPD) designation for ... Recessive Dystrophic Epidermolysis Bullosa (RDEB), a rare genetic skin ... and treatment is limited to supportive care. ... Orphan Drug Designation previously granted by the FDA in ...
(Date:1/18/2017)... 2017  Astellas Pharma Inc. (President and CEO: ... its participation in Access Accelerated, a global, multi-stakeholder ... prevention, diagnostics and treatment in low-income and lower-middle ... companies and in collaboration with the World Bank ... (UICC), Astellas will work towards the United Nations ...
(Date:1/17/2017)... DUBLIN , Jan 17, 2017 Research ... Pancreas Devices System Market 2016-2020" report to their offering. ... The global artificial ... during the period 2016-2020. Global Artificial Pancreas Devices System ... with inputs from industry experts. The report covers the market landscape ...
Breaking Medicine Technology: